Regulatory Science Update: FDA and International Serious Adverse Events Consortium Complete Third Data Release

Published: February 19, 2010
Regulatory Science Update: FDA and International Serious Adverse Events Consortium Complete Third Data Release

Data focus on genetic basis of drug-induced liver injury and serious skin reaction -

The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) today announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs).

(More)